A detailed history of Stockman Wealth Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Stockman Wealth Management, Inc. holds 1,663 shares of LLY stock, worth $1.31 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,663
Previous 2,368 29.77%
Holding current value
$1.31 Million
Previous $2.14 Million 31.26%
% of portfolio
0.24%
Previous 0.39%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $544,358 - $676,814
-705 Reduced 29.77%
1,663 $1.47 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $27,545 - $34,543
38 Added 1.63%
2,368 $2.14 Million
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $45,007 - $60,213
76 Added 3.37%
2,330 $1.81 Million
Q4 2023

Feb 01, 2024

SELL
$525.19 - $619.13 $27,835 - $32,813
-53 Reduced 2.3%
2,254 $1.31 Million
Q3 2023

Oct 31, 2023

BUY
$434.7 - $599.3 $21,735 - $29,964
50 Added 2.22%
2,307 $1.24 Million
Q2 2023

Aug 02, 2023

SELL
$350.74 - $468.98 $28,409 - $37,987
-81 Reduced 3.46%
2,257 $1.06 Million
Q1 2023

May 04, 2023

SELL
$310.63 - $364.82 $18,327 - $21,524
-59 Reduced 2.46%
2,338 $802,000
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $67,525 - $78,680
210 Added 9.6%
2,397 $876,000
Q3 2022

Nov 07, 2022

SELL
$296.48 - $337.87 $4,447 - $5,068
-15 Reduced 0.68%
2,187 $707,000
Q2 2022

Jul 28, 2022

BUY
$278.73 - $327.27 $32,332 - $37,963
116 Added 5.56%
2,202 $714,000
Q1 2022

May 05, 2022

BUY
$234.69 - $291.66 $139,171 - $172,954
593 Added 39.72%
2,086 $597,000
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $10,118 - $12,556
-45 Reduced 2.93%
1,493 $412,000
Q3 2021

Nov 02, 2021

BUY
$221.6 - $272.71 $13,960 - $17,180
63 Added 4.27%
1,538 $355,000
Q2 2021

Aug 12, 2021

BUY
$180.55 - $233.54 $25,277 - $32,695
140 Added 10.49%
1,475 $339,000
Q1 2021

May 05, 2021

SELL
$164.32 - $212.72 $51,760 - $67,006
-315 Reduced 19.09%
1,335 $249,000
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $20,221 - $26,757
155 Added 10.37%
1,650 $279,000
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $18,277 - $21,141
-125 Reduced 7.72%
1,495 $221,000
Q2 2020

Aug 11, 2020

SELL
$136.42 - $164.18 $12,550 - $15,104
-92 Reduced 5.37%
1,620 $266,000
Q1 2020

May 06, 2020

BUY
$119.05 - $147.35 $3,095 - $3,831
26 Added 1.54%
1,712 $237,000
Q4 2019

Feb 07, 2020

BUY
$106.92 - $132.43 $180,267 - $223,276
1,686 New
1,686 $222,000
Q3 2018

Nov 02, 2018

SELL
$85.86 - $107.31 $3.32 Million - $4.15 Million
-38,697 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $143,527 - $164,724
1,896 Added 5.15%
38,697 $3.3 Million
Q1 2018

May 10, 2018

BUY
$74.21 - $87.6 $258,250 - $304,848
3,480 Added 10.44%
36,801 $2.85 Million
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $25,073 - $26,894
306 Added 0.93%
33,321 $2.81 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $2.24 Million - $2.48 Million
29,006 Added 723.52%
33,015 $2.82 Million
Q2 2017

Aug 09, 2017

BUY
N/A
4,009
4,009 $330,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Stockman Wealth Management, Inc. Portfolio

Follow Stockman Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stockman Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stockman Wealth Management, Inc. with notifications on news.